Tag | Content |
---|
EnhancerAtlas ID | HS018-14665 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr21:34735780-34737850 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
LMX1B | MA0703.2 | chr21:34736960-34736971 | GTTTTAATTAA | + | 6.14 | Nr2f6(var.2) | MA0728.1 | chr21:34737740-34737755 | GAGGTCAGTAGTTCA | + | 6.07 | RARA | MA0729.1 | chr21:34737740-34737758 | GAGGTCAGTAGTTCAAGA | + | 6.1 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_10924 | chr21:34726302-34737379 | CD20 | SE_53413 | chr21:34736006-34737072 | Spleen | SE_58466 | chr21:34731200-34786233 | Ly1 | SE_60169 | chr21:34732700-34761220 | Ly4 | SE_60632 | chr21:34732666-34757447 | DHL6 | SE_61512 | chr21:34731229-34778660 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr21 | 34736638 | 34736920 | chr21 | 34736733 | 34736848 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I033363 | chr21 | 34735908 | 34737305 |
|
Enhancer Sequence | CCACTGCACT CCAGCCTGGG CGACAAAGTG AGACTCCGTC TCAAAAAAAA AAAAAAAAAA 60 AAAAAAGGAA ATTCTGTCAT GTGCTACAAC ATAGGTGAAG CTTGAGGACA TTATGTATGC 120 TATGTGAAAT AGGCCAGCAA CAAAAATATA AATACCATGT GATTCTACTT ACATGAGGTT 180 TCTAAAGCAA TCTAATTTCT AGAGACAGAA ATTAGACCGA TGATTGCTGG CGGCTCAAGG 240 AAGGGGAAAA TGGAGAGTTG TTCAGTGGCT ATAAAGCTTC AGTTTTTCAA GATGAAAAAG 300 TTCTGAAAAT AGGTAATACT ACTGAATTGT ATGTGTAAAA TGGTTAAGAT AGTAATTTTT 360 TTTTTTTTAA GAGACAGGGT TTCACTCTGT TGTCCAGACT GGCCTCAAAC TTCTATCTCA 420 AGCGATCCTT CCGCCTCAGC ATCTGGAGTA GCTGGGACTA TAGGTGTGCA CCACCACACC 480 CAGCTTTAAA AAGGTCACTA TTTTACTTAT TTATTTTTAA TTAGGGCAGA CTTAACAGTA 540 AGTGATTCAT CCTTGGTTTC TGATACATTA TTTCCTCCTT TTTCTAAAGG AAGTCTGCTC 600 TCTGCCATTA TTTTATCTGC CCAGAATACA AGTATAGTAA CGTCTTATTA CAAGCTATAC 660 AAATCCTTTT TCAAAGTGAG TGTGCAGACT GGGCTTGGCG GCTCACGCTT GTAATCCCAG 720 CAATTTGGGA GGCTGAGGTG GGTGAATCAC TTGAGGCCAG GAGTTTGAGA TCAGCCTGGC 780 CAACATGATG AAACCCCATC TCTACTAAAA GTACAAAAAT TAGCGGGGCA TGGTGGCACA 840 CACCTATAAT CCCAGGTACT CGGGAGGCTG AGGCAGGAGA ATCACTCGAA CCCGGGAGGC 900 AGAGGTTGCA GTGAGCCGGG AGTGCACCAC TGCACTCCAG CCTGGGCAAC AAAGTGAGAC 960 TCTGTCGTGA GTGTGCAGTT CATCACGTAG GCTTGTGTTG ATGTCAACAT AAGGCAAGTA 1020 CTTCCTCATT GCTCTACATC AGTGAAGAAA TGTGAACACC AAGGTTTAGA CTGAGAAGTA 1080 GGGCAGGGAG ATTGGATGGA GGTAAACTTT AAACATTTCA TGTCTTAATT TCTGCTTGTT 1140 TACCCCCAAG AGAATTTTAT AAATCCATTT ATTTCTTCAT GTTTTAATTA ACATCTAAAA 1200 TATTTCCTGA CACGTTTAAA TAGTTGCAAA AGAAATACTT TACAGTAAGT TGTAAATATT 1260 CACATTTTAA AATAAACTTG CTTTATCGCT CTTATAAATG CATTCAATGG AATCTCCTAT 1320 CAAAGCAATT TGATACCCAT CATTGTCTAC TTTGAAATTA CAGAAACTCG GCCAGACATG 1380 GCGGCTCACT CCTGTAATCC CAGCACTTTG GGAGGCCGAG GCGAGAGGAT TGTTTGAGTC 1440 CAAGAGTTCA AAACCATCCT GGACAACATA GTGAGACGAC CTTGTCTCTA CAAAAAAATG 1500 AACAGAATTA GCCAGGTGTG GTGGTGTGTG CCTGCAATTC TAGCTACTTG GGAAGCTGAG 1560 GTAGGAGGAT CTCTTGAGCC CTGGAGGTCA AGGTATAGTG AGCCAACATT GTGCCACTGC 1620 ACTCCAGCCT GGGCAACAGA GCAAGACCCT GTCTCAGAAA TATTTTTTTA AAAATTTTTT 1680 TAAAAAGAAA CTCCAGAAAC TGTTCTTTAT GGGTTCTGAA ACTTTACACC ATTTCCTTTC 1740 CTCCTTGAAT TCATATTCTT ATTCCCACAA AAGTTCATCT TCATGCAGTA GATTTATTGA 1800 TCATCTATCG TATATCTTTG CAACAAAAAA GTATATAAAT TGATATATTT CTTTTTATAT 1860 GATCATAGTC TCTGAATGTT AAAAAGAAAA AAATCTGGTT GGGTGCGGTG GCTCATGCTT 1920 GTAATCCCAG CACTTTGGGA GGCCGAGGTG GGTGGATCAC GAGGTCAGTA GTTCAAGACC 1980 AGCCTGGCCA AATGGTGAAA CCCCGTCTCT ACTAAAAATA CAAAAATTAG CTGGGCACGG 2040 TGGCAGGAGC CTGTAATCCC AGCTACTCAG 2070
|